Home › Endocrine Diseases › Illinois › Chicago
Endocrine Diseases clinical trials in Chicago, IL
4 studies for Endocrine Diseases are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
RecruitingPhase 3
- Ascendis Pharma Investigational Site, Chicago
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- University of Chicago, Chicago
Rare and Atypical Diabetes Network
RecruitingObservational study
- University of Chicago, Chicago
About Endocrine Diseases
The Endocrine system has eight major glands that make hormones. Diabetes is the most common endocrine disease in the USA.
More about Endocrine Diseases on MedlinePlus
Endocrine Diseases trials in other cities
- Houston, TX6 studies
- Washington, DC5 studies
- Boston, MA4 studies
- Seattle, WA3 studies
- New York City, NY3 studies
- Miami, FL3 studies
- San Antonio, TX3 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.